Matches in Wikidata for { <http://www.wikidata.org/entity/Q62817277> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q62817277 description "clinical trial" @default.
- Q62817277 description "ensayu clínicu" @default.
- Q62817277 description "klinisch onderzoek" @default.
- Q62817277 description "клінічне випробування" @default.
- Q62817277 description "临床试验" @default.
- Q62817277 name "ATR Kinase Inhibitor VX-970 and Carboplatin With or Without Docetaxel in Treating Participants With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q62817277 type Item @default.
- Q62817277 label "ATR Kinase Inhibitor VX-970 and Carboplatin With or Without Docetaxel in Treating Participants With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q62817277 prefLabel "ATR Kinase Inhibitor VX-970 and Carboplatin With or Without Docetaxel in Treating Participants With Metastatic Castration-Resistant Prostate Cancer" @default.
- Q62817277 P1050 Q62817277-6BBF7A66-DBFD-4C8E-B2D0-6001A32A5E67 @default.
- Q62817277 P1132 Q62817277-05096973-E9C5-4B66-BAD1-B31BFD2B1D57 @default.
- Q62817277 P1476 Q62817277-27FA493B-0EB2-4235-B76F-AC4AE965F553 @default.
- Q62817277 P17 Q62817277-F1E25408-338B-4DF3-856D-A50143B49538 @default.
- Q62817277 P2899 Q62817277-6383C34A-9AED-4253-A528-D105CD170E80 @default.
- Q62817277 P3098 Q62817277-F27BA05F-D6A5-447F-96BC-9822683374F4 @default.
- Q62817277 P31 Q62817277-9977913A-C079-4AA1-8188-68E4E4C216EF @default.
- Q62817277 P4844 Q62817277-6CA333CD-0C69-4DA6-9D3C-A3A6ADFB4127 @default.
- Q62817277 P4844 Q62817277-95F379D1-2204-42D8-AD5D-7389FD18E927 @default.
- Q62817277 P580 Q62817277-89E6F96C-C5E5-4A4F-8030-671EF1067857 @default.
- Q62817277 P582 Q62817277-F8479122-DDF3-4748-866F-79A5D58B85A5 @default.
- Q62817277 P6099 Q62817277-3F5FBC60-E720-409F-85BE-FA5F3C5CBE0E @default.
- Q62817277 P6153 Q62817277-126A7A2B-6974-426C-A762-FD430C2F1865 @default.
- Q62817277 P6153 Q62817277-58F31D89-D9CF-4377-B6E3-72E1A4DFB61D @default.
- Q62817277 P6153 Q62817277-7430AA3F-2F50-4CBD-8EC6-D0F6E378E868 @default.
- Q62817277 P6153 Q62817277-75DA096E-1DA4-43B9-9343-8666512B9965 @default.
- Q62817277 P6153 Q62817277-890238CB-C058-49C6-840A-4964B91482D0 @default.
- Q62817277 P6153 Q62817277-BC231951-4DB2-4FAD-84B5-CC26B12F5344 @default.
- Q62817277 P6153 Q62817277-E44F53CB-2AE3-465F-88D8-BCB31CF6D723 @default.
- Q62817277 P8005 Q62817277-4A86CEF5-06A9-491D-A269-C63EB0348512 @default.
- Q62817277 P8005 Q62817277-B580061D-2997-4E32-AD85-EF36AC1BB4C7 @default.
- Q62817277 P8363 Q62817277-F36DBE48-FD5D-4E6D-BA60-D3CF57525F0D @default.
- Q62817277 P859 Q62817277-6548B0F9-F0AD-4E77-9E41-7BD440D17C8B @default.
- Q62817277 P1050 Q33525 @default.
- Q62817277 P1132 "+130" @default.
- Q62817277 P1476 "A Phase 2 Study of M6620 in Combination With Carboplatin Compared With Docetaxel in Combination With Carboplatin in Metastatic Castration-Resistant Prostate Cancer" @default.
- Q62817277 P17 Q30 @default.
- Q62817277 P2899 "+18" @default.
- Q62817277 P3098 "NCT03517969" @default.
- Q62817277 P31 Q30612 @default.
- Q62817277 P4844 Q415588 @default.
- Q62817277 P4844 Q420436 @default.
- Q62817277 P580 "2018-10-12T00:00:00Z" @default.
- Q62817277 P582 "2020-12-06T00:00:00Z" @default.
- Q62817277 P6099 Q42824440 @default.
- Q62817277 P6153 Q1159198 @default.
- Q62817277 P6153 Q235034 @default.
- Q62817277 P6153 Q309331 @default.
- Q62817277 P6153 Q4897536 @default.
- Q62817277 P6153 Q49112 @default.
- Q62817277 P6153 Q499451 @default.
- Q62817277 P6153 Q622664 @default.
- Q62817277 P8005 Q76649708 @default.
- Q62817277 P8363 Q78089383 @default.
- Q62817277 P859 Q664846 @default.